Transcutaneous Bilirubinometry in Neonates
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01422655|
Recruitment Status : Completed
First Posted : August 24, 2011
Last Update Posted : January 24, 2012
Objective: To assess the accuracy of transcutaneous bilirubin (TcB) measurements in neonates, in relation to gestational age (GA), time (postnatal hour) and site (forehead, sternum, knee) of measurements.
Hypothesis: Using (or combining) different sites for TcB determination might improve the accuracy of TcB in relation to the time of measurement and the GA of the neonate.
Methods: The study will include neonates >32 weeks' gestation cared for in the well-baby nursery and NICU of the University Hospital of Patras, from September to December 2011. Data such as sex, gestational age, gestation and perinatal information, mother's and infant's ABO group and Rh, G6PD deficiency, Coombs test, type of delivery and complications, birthweight, postnatal medications and interventions, type and volume of feeding, and extension of jaundice, will be collected.
TcB measurements will be performed using the BiliCheck bilirubinometer (according to the standard protocol) at 3 different sites: forehead, sternum and knee. Total serum bilirubin (TSB) values will be obtained using the heel stick technique, and measurements will be performed by a direct spectrophotometric device (Unistat bilirubinometer, Richert, Depew, NY). The accuracy of the device has been validated previously. TSB measurements will be performed within 5 minutes of the TcB measurements.
At each occasion TcB measurements (3), the corresponding TSB value, the time of measurement (postnatal hours), and the actual weight will be noted.
Statistics: The agreement between TcB and TSB values will be assessed using the Bland-Altman % method. The independent and joint effects of GA and time of measurement on bias will be evaluated by multivariate regression analysis.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||255 participants|
|Official Title:||Accuracy of Transcutaneous Bilirubin Determinations in Neonates: The Effect of Gestational Age, Time and Site of Measurement|
|Study Start Date :||August 2011|
|Actual Primary Completion Date :||January 2012|
|Actual Study Completion Date :||January 2012|
- Accuracy characteristics of TcB as compared to TSB [ Time Frame: Tcb vs TSB measurements at any time from birth to 120 postnatal hours ]TcB measurements performed at 3 different sites (forehead, sternum, knee)will be compared with the corresponding TSB value. The agreement between TcB and TSB values will be assessed using the Bland-Altman % method. The effect of gestational age and time of measurement (postnatal hour)on TcB bias will be explored by multivariate regression analysis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01422655
|Neonatal Intensive Care Unit, University Hospital of Patras|
|Patras, Greece, 26504|
|Principal Investigator:||Sotirios Fouzas, MD||Neonatal Intensive Care Unit, University Hospital of Patras|
|Study Director:||Anastasia Varvarigou, Prof||Neonatal Intensive Care Unit, University Hospital of Patras|
|Principal Investigator:||Eugenia Panagiotopoulou, MD||Neonatal Intensive Care Unit, University Hospital of Patras|